CareDx, Inc. CDNA
63.68
2.31
3.76%
as of 25 Sep
- Market cap
- $3.2B
- P/E
- 29.6×
Follow CDNA
Growth Flags
show if company had growth for consecutive years
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
13.26 | 0.00 | 0.00 | 11.18 |
+8 more quarters Free account |
P/S ratio |
3.20 | 2.15 | 2.64 | 2.13 | |
P/FCF ratio |
17.64 | 14.03 | 29.06 | 21.49 | |
P/Operating CF |
47.93 | 204.94 | 46.99 | 20.44 | |
P/B ratio |
3.45 | 2.83 | 3.31 | 2.45 | |
Price to Tangible BV |
3.95 | 3.68 | 4.35 | 3.22 | |
EV/Sales |
2.46 | 1.78 | 2.27 | 1.69 | |
EV/EBITDA |
8.68 | 124.06 | 0.00 | 7.31 | |
EV/Operating CF |
12.05 | 10.09 | 20.51 | 14.20 | |
EV/FCF |
13.57 | 11.63 | 24.95 | 17.02 | |
Quick Ratio |
4.35 | 2.93 | 2.45 | 2.44 | |
Current Ratio |
4.58 | 3.40 | 2.86 | 3.03 | |
Net Debt/EBITDA |
(3.17) | (25.20) | 54.39 | (23.96) | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.94 | 0.92 | 0.84 | 0.79 | |
Operating CF/Net income |
0.28 | 1.54 | (5.20) | 22.30 | |
Capex/Depreciation |
(0.41) | (0.61) | (0.71) | (0.24) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
16.96% | 18.20% | 17.81% | 16.76% | |
Selling, General and Administrative Expense of Revenue |
56.35% | 51.71% | 55.00% | 52.85% | |
Intangible Assets out of Total Assets |
0.10 | 0.18 | 0.18 | 0.17 | |
Share Based Compensation of Revenue |
8.07% | 8.33% | 7.46% | 8.41% | |
Graham Net Nets |
0.22 | 0.19 | 0.15 | 0.23 | |
Graham Number |
20.00 | 0.00 | 0.00 | 13.17 | |
Earnings Yield |
7.54% | (0.92%) | (2.12%) | 8.94% | |
Free Cash Flow Yield |
5.67% | 7.13% | 3.44% | 4.65% | |
Revenue per Share |
2.56 | 2.30 | 2.03 | 1.91 | |
Operating CF per Share |
0.59 | 0.08 | 0.40 | 0.71 | |
Capex per Share |
(0.04) | (0.07) | (0.04) | (0.04) | |
Free Cash Flow per Share |
0.56 | 0.01 | 0.36 | 0.67 | |
Cash per Share |
7.26 | 3.66 | 3.33 | 3.70 | |
Shareholders Equity per Share |
8.27 | 6.13 | 5.69 | 5.93 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
8.27 | 6.13 | 5.69 | 5.93 | |
Free Cash Flow |
28.75 | 0.51 | 19.39 | 35.38 | |
Working Capital |
335.53 | 190.24 | 167.28 | 201.24 | |
Capital Expenditures |
(1.86) | (3.82) | (1.97) | (1.98) | |
Net Current Asset Value |
321.83 | 171.87 | 147.01 | 179.11 | |
EV/EBIT |
10.44 | 0.00 | 0.00 | 10.14 | |
Capex to Sales |
0.01 | 0.03 | 0.02 | 0.02 | |
Net Profit Margin |
83.85% | 2.39% | (3.79%) | 1.67% | |
Price to Operating Income |
13.57 | 0.00 | 0.00 | 12.80 | |
| Other line items | |||||
Average Receivables |
50.87 | 58.04 | 53.62 | 57.24 | |
Average Payables |
9.68 | 8.57 | 8.84 | 8.92 | |
Average Inventory |
17.45 | 24.67 | 23.10 | 23.80 | |
Average Assets |
488.62 | 450.35 | 452.14 | 454.65 | |
Average Common Equity |
376.48 | 346.44 | 340.77 | 292.19 |
Columns are period end dates